Stay updated on 4D-125 in XLRP Patients Clinical Trial
Sign up to get notified when there's something new on the 4D-125 in XLRP Patients Clinical Trial page.

Latest updates to the 4D-125 in XLRP Patients Clinical Trial page
- ChecktodayChange DetectedThe page footer reflects a ClinicalTrials.gov site revision update from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe clinical trial record for 4D-125 in patients with X-linked retinitis pigmentosa is now displayed, including the study design, eligibility criteria, locations, and outcome measures.SummaryDifference43%

- Check21 days agoChange DetectedThe page continues to display a 403 Forbidden error, while the footer shows site revision v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces NIH’s transition from using the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site revision label on the 403 error page changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to 4D-125 in XLRP Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 4D-125 in XLRP Patients Clinical Trial page.